As demand for GLP-1 drugs soars, manufacturers like Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro, Zepbound) face growing calls to lower prices
A single pre-filled human insulin pen could be sold at a profit for as little as $0.94, MSF said, but prices ranged from $1.99 to $90.69
Pros: Much cheaper ($40$120 per 5mg vial, translating to $150$500/month depending on dose), no prescription required, widely available Cons: No quality control, contamination risk, no medical oversight, legal ambiguity, no recourse if something goes wrong Risk mitigation: Third-party testing through labs like Janoshik, vetting vendors through Reddit and peptide forums, starting with small test orders Grey Market Risks Research peptides are not FDA-regulated
Choung, R
First, immune cells rush to injury sites to stop bleeding and clear damage
Our data suggest that oxidative stress promotes HO-1 translocation from the cytosol into mitochondria where it catalyzes heme degradation and iron release